Skip to main content.

11th Annual Vincent and Nancy DiGirolamo Cancer Symposium


You're cordially invited to the 11th Annual Vincent & Nancy DiGirolamo Cancer Symposium, presented by Summa Health Cancer Institute. Please join us at the 2018 Annual Cancer Symposium on "Integrative and Personalized Cancer Care." Our featured speakers will discuss various aspects of research. 


Peter A. Johnstone, M.D.  Acupuncture for Cancer Symptom Management


Dr. Johnstone received his MD degree from the Uniformed Services University of Health Sciences, Bethesda, MD. He completed a Transitional Internship at National Naval Medical Center and a Radiation Oncology Residency at the National Cancer Institute. Dr. Johnstone served in the United States Navy, retiring in 2003. He then served as Professor of Radiation Oncology and Hematology/ Oncology at Emory University School of Medicine from 2003-2007. He was Director of the Survivorship Program at the Emory Winship Cancer Institute during this period. Dr. Johnstone was appointed as Chair and William A. Mitchell Professor of Radiation Oncology at Indiana University School of Medicine in 2007. He was also assigned as President and Chief Executive Officer of the IU Health Proton Therapy Center, and Director of the Indiana University cyclotron. He assumed responsibilities as Clinical Director and Vice Chair at Moffitt in 2014. Dr. Johnstone has clinical interest in pediatric, and genitourinary malignancies and sarcomas. His recent clinical trials have involved acupuncture as symptom control in cancer patients, and his recent publications have dealt with the use of proton radiotherapy in children. He is a Fellow of the American College of Radiology and serves on the ACR Board of Chancellors. In 2007 he was President of the Society for Integrative Oncology, and in 2011 was President of the American Radium Society.


Mark A. Rosenberg, M.D. Immunogenic and Metronomic Chemotherapy; Is it Time for a Paradigm Shift?


Dr. Rosenberg is the founder and medical director of the AMT’s Institute for Healthy Aging and Integrative Cancer Therapeutics, which together integrate traditional western medicine and the latest science with complementary and alternative medicine to optimize patients’ health. Dr. Rosenberg received his undergraduate degree from the University of Pennsylvania, and his doctorate in medicine from Georgetown University School of Medicine. He then completed his residency and board certification in emergency medicine in San Antonio, Texas, at Brooke Army Medical Center, where he was recognized with the “Teacher and Resident of the Year” award. He then began his career as an accomplished emergency physician and medical professor, first in the army where he achieved the rank of Major and then with a number of leading hospitals. However, after a decade of practice, he began to question some of the traditional standards of care that he had been taught in his medical training, because they were not meeting the needs of his patients. Since that time over a decade ago, Dr. Rosenberg has become a leading researcher and clinician in the areas of healthy aging and integrated cancer therapy. After diagnosing his mother with stage 4 lung cancer, Dr. Rosenberg began studying cancer, specifically, tumor metabolism, as well as treatments to target cancer stem cells. He has since co-founded an oncologic pharmaceutical company, where he collaborates with several universities, with the goal being the development of the first drug that eradicates cancer stem cells.

Dr. Rosenberg serves on the board of directors for the American Academy of Anti-Aging medicine, and is an advisor and lecturer for the academy, as well as the program director of the first Integrative

Cancer Fellowship in the U.S. In addition, Dr. Rosenberg is Chief Medical Officer of U.S. operations for Laboratory for Advanced Medicine, Inc. (LAM). LAM has developed a liquid biopsy that detects cancer through evaluation of DNA methylation patterns; Dr. Rosenberg is involved in initiating clinical trials with the FDA to further this exciting area of cancer research.


Shanu Khanuja, A Cultural Journey Through Cancer:  A Survivor's Story


This year our survivor story is Shanu Khanuja who was diagnosed in March of 2017 with Stage 3 Invasive DCIS Breast Cancer. She is from Warren, Ohio and daughter to two physicians, sister to two siblings, aunt to three children (soon to be four) and foster mom to many dogs. Her career has been focused on the healthcare industry. She has worked for 20+ years in strategic planning and operations for pharmaceutical and biotech marketing. She was born in Ohio and has lived in California. Shanu recently moved to Chicago, IL and she’s happy to be back closer to home. With her diagnosis last year, she has been focusing her time to help patients get the resources and answers they need. She is volunteering with the American Brain Tumor Association and Imerman Angels. She is actively trying to make a difference in patient’s lives and also going back to her pharma colleagues to provide them the insights she’s learned.



    7:30 a.m. Welcome, Opening Remarks


Gilbert D. Padula, M.D. – Vincent and Nancy DiGirolamo Endowed Chair in Oncology, Medical Director, Summa Health Cancer Institute


    7:45 a.m. Keynote Speaker: Peter A. Johnstone, M.D. Acupuncture and Radiation Patients


    8:45 a.m. Mark A. Rosenberg, M.D., Integrated Cancer Therapy


    9:45 a.m.  Break


    10:00 a.m. Shanu Khanuja, A Cultural Journey through Cancer: A survivor’s Story


    11:00 a.m.  Dismissal


Please reserve your seat by Friday, October 12.


Space is limited.





Employees are encouraged to park in their designated lots or garages. All other guests are encouraged to park in the Summa Health South Pavilion garage, located at 55 Arch Street.




There are no times currently scheduled for this event.


Options to Request an Appointment

If your situation is an emergency, call 911.